The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
CX 3 C Chemokine Fractalkine in Pulmonary Arterial Hypertension
Abstract
Perivascular infiltrates composed of macrophages and lymphocytes have been described in lung biopsies of patients displaying pulmonary arterial hypertension (PAH), suggesting that circulating inflammatory cells can be recruited in affected vessels. CX(3)C chemokine fractalkine is produced by endothelial cells and promotes leukocyte recruitment, but unlike other chemokines, it can capture leukocytes rapidly and firmly in an integrin-independent manner under high blood flow. We therefore hypothesized that fractalkine may contribute to pulmonary inflammatory cell recruitment in PAH. Expression and function of the fractalkine receptor (CX(3)CR1) were studied by use of triple-color flow cytometry on circulating T-lymphocyte subpopulations in freshly isolated peripheral blood mononuclear cells from control subjects and patients with PAH. Plasma-soluble fractalkine concentrations were measured by enzyme-linked immunosorbent assay. Finally, fractalkine mRNA and protein expression were analyzed in lung samples by reverse transcriptase-polymerase chain reaction or in situ hybridization and immunohistochemistry, respectively. In patients with PAH, CX(3)CR1 expression and function are upregulated in circulating T-lymphocytes, mostly of the CD4+ subset, and plasma soluble fractalkine concentrations are elevated, as compared with control subjects. Fractalkine mRNA and protein product are expressed in pulmonary artery endothelial cells. We conclude that inflammatory mechanisms involving chemokine fractalkine and its receptor CX(3)CR1 may have a role in the natural history of PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80438-9 · Cited by 1,445
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,379
Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176
Humbert, M., Monti, G., Brenot, F., Sitbon, O., Portier, A., Grangeot-Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Emilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 797
Self-citationTuder, R. M., Groves, B. Μ., Badesch, D. B., & Voelkel, N. F. (1994) · PubMed Central · Cited by 784
Trembath, R. C., Thomson, J. R., Machado, R. D., Morgan, N. V., Atkinson, C., Winship, I., Simonneau, G., Galie, N., Loyd, J. E., Humbert, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450503 · Cited by 725
Self-citationFong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T., & Patel, D. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1413 · Cited by 679
Garton, K. J., Gough, P. J., Blobel, C. P., Murphy, G., Greaves, D. R., Dempsey, P. J., & Raines, E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106434200 · Cited by 639
BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary Hypertension
Machado, R. D., Pauciulo, M. W., Thomson, J. R., Lane, K. B., Morgan, N. V., Wheeler, L., Phillips III, J. A., Newman, J., Williams, D., Galiè, N., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316947 · Cited by 535
Self-citationCX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
Tripp, R. A., Jones, L. P., Haynes, L. M., Zheng, H., Murphy, P. M., & Anderson, L. J. (2001) · Nature Immunology · doi:10.1038/90675 · Cited by 456
Primary Pulmonary Hypertension: A Vascular Biology and Translational Research “Work in Progress”
Archer, S., & Rich, S. (2000) · Circulation · doi:10.1161/01.cir.102.22.2781 · Cited by 354
Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease
Moatti, D. (2001) · Blood · doi:10.1182/blood.v97.7.1925 · Cited by 349
Wilbanks, A., Zondlo, S. C., Murphy, K., Mak, S., Soler, D., Langdon, P., Andrew, D. P., Wu, L., & Briskin, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5145 · Cited by 324
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses
Fraticelli, P., Sironi, M., Bianchi, G., D’Ambrosio, D., Albanesi, C., Stoppacciaro, A., Chieppa, M., Allavena, P., Ruco, L., Girolomoni, G., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11517 · Cited by 321
Humbert, M., Monti, G., Fartoukh, M., Magnan, A., Brenot, F., Rain, B., Capron, F., Galanaud, P., Duroux, P., Simonneau, G., et al. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11030554 · Cited by 306
Self-citationChemokine RANTES in Severe Pulmonary Arterial Hypertension
DORFMÜLLER, P., ZARKA, V., DURAND-GASSELIN, I., MONTI, G., BALABANIAN, K., GARCIA, G., CAPRON, F., COULOMB-LHERMINÉ, A., MARFAING-KOKA, A., SIMONNEAU, G., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.4.2012112 · Cited by 288
Self-citationCombadiere, C., Salzwedel, K., Smith, E. D., Tiffany, H. L., Berger, E. A., & Murphy, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23799 · Cited by 284
McDermott, D. H., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Merrell, M. N., Epstein, N., Quyyumi, A. A., & Murphy, P. M. (2001) · Circulation Research · doi:10.1161/hh1701.095642 · Cited by 256
Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis
Ruth, J. H., Volin, M. V., Haines, G. K., Woodruff, D. C., Katschke, K. J., Woods, J. M., Park, C. C., Morel, J. C. M., & Koch, A. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1568::aid-art280>3.0.co;2-1 · Cited by 238
Molecular Uncoupling of Fractalkine-mediated Cell Adhesion and Signal Transduction
Haskell, C. A., Cleary, M. D., & Charo, I. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10053 · Cited by 235
Goda, S., Imai, T., Yoshie, O., Yoneda, O., Inoue, H., Nagano, Y., Okazaki, T., Imai, H., Bloom, E. T., Domae, N., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4313 · Cited by 224
Voelkel, N. F., Tuder, R. M., Bridges, J., & Arend, W. P. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.11.6.7946395 · Cited by 212
Feng, L., Chen, S., Garcia, G. E., Xia, Y., Siani, M. A., Botti, P., Wilson, C. B., Harrison, J. K., & Bacon, K. B. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00604.x · Cited by 192
Tong, N., Perry, S. W., Zhang, Q., James, H. J., Guo, H., Brooks, A., Bal, H., Kinnear, S. A., Fine, S., Epstein, L. G., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1333 · Cited by 183
Greaves, D. R., Häkkinen, T., Lucas, A. D., Liddiard, K., Jones, E., Quinn, C. M., Senaratne, J., Green, F. R., Tyson, K., Boyle, J., et al. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.923 · Cited by 180
Papadopoulos, E. J., Sassetti, C., Saeki, H., Yamada, N., Kawamura, T., Fitzhugh, D. J., Saraf, M. A., Schall, T. J., Blauvelt, A., Rosen, S. D., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199908)29:08<2551::aid-immu2551>3.0.co;2-t · Cited by 170
A Role for Fractalkine and Its Receptor (CX3CR1) in Cardiac Allograft Rejection
Robinson, L. A., Nataraj, C., Thomas, D. W., Howell, D. N., Griffiths, R., Bautch, V., Patel, D. D., Feng, L., & Coffman, T. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6067 · Cited by 166
Lucas, A. D., Chadwick, N., Warren, B. F., Jewell, D. P., Gordon, S., Powrie, F., & Greaves, D. R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64034-5 · Cited by 165
Generation and Analysis of Mice Lacking the Chemokine Fractalkine
Cook, D. N., Chen, S., Sullivan, L. M., Manfra, D. J., Wiekowski, M., Prosser, D. M., Vassileva, G., & Lira, S. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3159-3165.2001 · Cited by 157
RISK FACTORS FOR PULMONARY ARTERIAL HYPERTENSION
Humbert, M. J. C., Nunès, H., Sitbon, O., Parent, F., Hervé, P., & Simonneau, G. (2001) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70284-7 · Cited by 139
Self-citationUnique Role of the Chemokine Domain of Fractalkine in Cell Capture
Haskell, C. A., Cleary, M. D., & Charo, I. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005731200 · Cited by 124
Endothelial Dysfunction in Pulmonary Hypertension
Loscalzo, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270209 · Cited by 123
Autoantibodies in patients with primary pulmonary hypertension: Association with anti-Ku
Isern, R. A., Yaneva, M., Weiner, E. S., Parke, A. L., Rothfield, N. F., Dantzker, D. R., Rich, S., & Arnett, F. C. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90238-7 · Cited by 111
Treatment of pulmonary hypertension secondary to connective tissue diseases
Sanchez, O., Humbert, M. J. C., Sitbon, O., & Simonneau, G. (1999) · Thorax · doi:10.1136/thx.54.3.273 · Cited by 99
Self-citationFoussat, A., Bouchet‐Delbos, L., Berrebi, D. D., Durand–Gasselin, I., L’Herminé, A. C., Krzysiek, R., Galanaud, P., Lévy, Y., & Émilie, D. (2001) · Blood · doi:10.1182/blood.v98.6.1678 · Cited by 94
Self-citationUltrastructure and Function of the Fractalkine Mucin Domain in CX3C Chemokine Domain Presentation
Fong, A. M., Erickson, H., Zachariah, J. P., Poon, S., Schamberg, N. J., Imai, T., & Patel, D. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3781 · Cited by 90
Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart
Harrison, J. K., Jiang, Y. J., Wees, E. A., Salafranca, M. N., Liang, H., Feng, L., & Belardinelli, L. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.6.937 · Cited by 89
Papadopoulos, E. J., Fitzhugh, D. J., Tkaczyk, C., Gilfillan, A. M., Sassetti, C. M., Metcalfe, D. D., & Hwang, S. T. (2000) · European Journal of Immunology · Cited by 88
Kimura, H., Kasahara, Y., Kurosu, K., Sugito, K., Takiguchi, Y., Terai, M., Mikata, A., Natsume, M., Mukaida, N., Matsushima, K., et al. (1998) · PubMed · Cited by 85
Raychaudhuri, S. P., Jiang, W.-Y., & Farber, E. M. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04219.x · Cited by 68
Upregulation of Fractalkine in Human Crescentic Glomerulonephritis
Furuichi, K., Wada, T., Iwata, Y., Sakai, N., Yoshimoto, K., Shimizu, M., Kobayashi, K., Takasawa, K., Kida, H., Takeda, S.-I., et al. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000045936 · Cited by 58
Zou, W., Foussat, A., Houhou, S., Durand–Gasselin, I., Dulioust, A., Bouchet, L., Galanaud, P., Lévy, Y., & Émilie, D. (1999) · AIDS · doi:10.1097/00002030-199903110-00003 · Cited by 50
Self-citationQuantification of cytokine gene expression by competitive PCR using a colorimetric assay.
Zou, W., Durand–Gasselin, I., Dulioust, A., Maillot, M., Galanaud, P., & Émilie, D. (1995) · PubMed · Cited by 37
Self-citationHoerr, I. (2000) · doi:10.1002/1521-4141(200001)30:1
Cited by
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationCellular and molecular pathobiology of pulmonary arterial hypertension
Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.029 · Cited by 1,576
Self-citationInflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029
Self-citationMolecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33452 · Cited by 880
Metadata
- Authors
- Balabanian, K., Foussat, A., Dorfmüller, P., Durand-Gasselin, I., Capel, F., Bouchet-Delbos, L., Portier, A., Marfaing-Koka, A., Krzysiek, R., Rimaniol, A.-C., Simonneau, G., Emilie, D., & Humbert, M.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05-15
- Volume
- 165
- Issue
- 10
- Pages
- 1419-1425
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2155013589
- Cited by
- 274
- References
- 49
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.